http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2183425-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d825145795e4a6fea76269e9d80929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bcd836afaf807f9b5f5ee7b643d4dce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6370b37a3ebc7900df7c68e71d6fe895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c217c7867a4ce00adeaf17bcf90f295
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
filingDate 2001-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d90913a82960a2a675dcbd867ffe09c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4f3d6ce5cc78e0f7f124fd18ebf0542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d4ce3529c697404f64021218e5175d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_763b5b90d9526fcf9959786e138bab83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886e56320255b588b77f36160cdfcf60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afdad483480e3058fd5de2169ae53375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_915685ab16addf91db1c984b6d7c7362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b0d7d31530bd020e80e6d440a7b7f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f5d7c95e2188f2f5a336604c648eb9a
publicationDate 2002-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2183425-C1
titleOfInvention Method for creating ureterosigmoidostomy
abstract FIELD: medicine. SUBSTANCE: method involves transecting intestine at the rectosigmoid region of along the countermesenteric edge. Tunnel is built for implanting the ureter and creating rectosigmoid reservoir. The tunnel is built in extramural way. The posterior reservoir wall is formed by stitching seroserous sutures. The ureters are arranged on the built wall towards each other. The ureters are fixed on intestine wall. Intestine edges are sutured one to another. EFFECT: enhanced effectiveness of antireflux protection; reduced risk of ureteral stricture. 3 dwg
priorityDate 2001-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408264951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411143462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877

Total number of triples: 33.